Illustration of peritoneal dialysis in Hong Kong

Hong Kong's Kidney Care Revolution: Why 'PD First' Is Saving Lives and Money

"Discover how a pioneering dialysis policy is transforming healthcare and improving outcomes for patients with kidney disease."


In the bustling city of Hong Kong, a quiet revolution is taking place within its healthcare system. It's a revolution driven by a simple, yet powerful, principle: prioritizing peritoneal dialysis (PD) for patients with kidney disease. This 'PD-first' policy, implemented for over three decades, has not only achieved remarkable success but also serves as a model for other regions grappling with the rising burden of end-stage renal disease (ESRD).

The numbers speak volumes. In Hong Kong, the average cost of hemodialysis (HD) per patient is more than double that of PD. As the prevalence of ESRD continues to rise globally, the financial strain on healthcare systems is immense. This article dives deep into the 'PD-first' policy, exploring its benefits, the challenges it faces, and the innovative strategies that are key to its continued success.

We'll explore why PD is often the preferred initial treatment, the importance of addressing patient issues, and how Hong Kong is enhancing HD support and promoting organ transplantation to ensure the long-term sustainability of this life-saving approach. This comprehensive approach offers not just financial advantages but also offers patients a better quality of life.

The 'PD-First' Policy: A Foundation for Success

Illustration of peritoneal dialysis in Hong Kong

The roots of Hong Kong's 'PD-first' policy trace back to 1969, with the introduction of both maintenance hemodialysis and intermittent PD. However, it was the introduction of continuous ambulatory peritoneal dialysis (CAPD) in 1980 that truly shifted the landscape. CAPD's cost-effectiveness and therapeutic benefits paved the way for PD to become the primary dialysis modality.

Under this policy, all patients with chronic kidney disease requiring dialysis are initially treated with PD, unless specific medical conditions contraindicate it. The Hong Kong Hospital Authority only reimburses HD when medical reasons prevent the use of PD. This approach has led to a remarkable transformation in patient outcomes and healthcare efficiency.

  • Cost-Effectiveness: PD is significantly less expensive than HD, reducing the financial burden on the healthcare system.
  • Improved Patient Outcomes: Studies have shown that PD can lead to better patient survival and quality of life.
  • Home-Based Therapy: PD allows patients to receive treatment at home, promoting independence and reducing hospital visits.
  • Enhanced Quality of Life: Patients on PD often report better mobility and freedom compared to those on HD.
In 2012, an impressive 72.9% of the dialysis population in Hong Kong was treated with PD, the highest rate globally. This high rate underscores the success of the PD-first approach in making dialysis care more accessible and effective for the majority of patients.

A Model for the Future of Kidney Care

Hong Kong's 'PD-first' policy offers a compelling example of how innovative healthcare strategies can improve patient outcomes, reduce costs, and enhance the overall quality of life. As the global burden of kidney disease continues to rise, the lessons learned from Hong Kong's success story provide valuable insights for healthcare providers, policymakers, and patients worldwide. By prioritizing patient-centered care and embracing the benefits of PD, we can work towards a future where the challenges of ESRD are met with effective, sustainable solutions.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.